Book chapter
Immunotherapy for Malignant Gliomas
Malignant Gliomas, pp 289-315
01 Jan 2012
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Malignant gliomas invade and infiltrate the surrounding brain, often making complete surgical excision impossible. They are also among the most radiation- and chemotherapy-resistant cancers. As such, innovative treatment approaches are desperately needed. Immunotherapy is a particularly appealing strategy because of the potential ability for immune cells to traffic to and destroy infiltrating tumor cells, which by the time of diagnosis have permeated into normal brain parenchyma far beyond the borders of the tumor recognizable by conventional imaging methods or during surgery. This chapter reviews current strategies for modulating the immune system for the treatment of malignant gliomas.
Metrics
2 Record Views
Details
- Title
- Immunotherapy for Malignant Gliomas
- Creators
- Richard G. Everson - College Station Medical CenterElena I. Fomchenko - College Station Medical CenterDavid S. Foulad - College Station Medical CenterDominique N. Lisiero - College Station Medical CenterLinda M. Liau - College Station Medical Center
- Contributors
- A Chakravarti (Editor)M Fuss (Editor)
- Publication Details
- Malignant Gliomas, pp 289-315
- Series
- Radiation Medicine Rounds
- Publisher
- Demos Medical Publications; NEW YORK
- Number of pages
- 27
- Resource Type
- Book chapter
- Language
- English
- Academic Unit
- Neurology
- Web of Science ID
- WOS:000318317300009
- Other Identifier
- 991022004878304721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Oncology
- Radiology, Nuclear Medicine & Medical Imaging